ICD Code G89.3

ICD code G89.3 is neoplasm-related pain, which refers to pain caused by cancer or tumors, whether the pain is acute or chronic.

1. Presence of pain that is directly attributable to a diagnosed neoplasm (malignant or benign tumor).

2. Pain may be acute (sudden onset and short duration) or chronic (persistent or recurring over a longer period).

3. Pain is not better explained by another pain disorder or unrelated medical condition.

4. Documentation clearly links the pain to the neoplastic process, either due to tumor invasion, compression, or treatment-related effects.

5. Pain persists despite or in the absence of other symptoms commonly associated with the neoplasm.

6. Clinical assessment confirms that the primary reason for the encounter or treatment is the management of pain related to the neoplasm.

Relevant CPT codes that may be used to treat ICD code G89.3 include:

- 99201–99499 (Evaluation and Management services)

- 96372 (Therapeutic, prophylactic, or diagnostic injection)

- 62320–62327 (Injection, anesthetic agent and/or steroid, epidural or subarachnoid)

- 64400–64530 (Nerve block and neurolytic procedures)

- 63650 (Percutaneous implantation of neurostimulator electrode array)

- 95970–95972 (Electronic analysis of implanted neurostimulator pulse generator system)

- 77003 (Fluoroscopic guidance for needle placement)

- 96413–96417 (Chemotherapy administration, if pain management is related to chemotherapy)

- 20552–20553 (Trigger point injections)

- 27299 (Unlisted procedure, pelvis or hip joint, for pain management procedures not otherwise specified)

CPT code selection should be based on the specific pain management intervention provided for ICD code G89.3.

Schedule a demo to see how MD Clarity’s RevFind software can automatically read your contracts and identify underpayments for CPT codes associated with ICD code G89.3. Discover how easy it is to ensure you’re being paid accurately for every claim—book your personalized walkthrough today.